Literature DB >> 9548329

Leiomyosarcoma of the inferior vena cava. Resection and reconstruction of the renal vein using the gonadal vein.

R Yamaguchi1, A Yamaguchi, M Isogai, A Hori, Y Kin.   

Abstract

We succeeded in surgically resecting a leiomyosarcoma of the inferior vena cava (IVC), which originated at the confluent portion of the right renal vein (RRV), together with the IVC and RRV, and also were able to preserve the right kidney by reconstructing the RRV with end-to-end anastomosis using the right gonadal vein. A good blood flow of the reconstructed RRV was thereafter confirmed by color Doppler ultrasonography, and the renal function was also satisfactory. This new procedure, a reconstruction of the RRV using the gonadal vein, has not been previously reported, but is considered to be an easy and effective method which enables the surgeon to preserve the normal right kidney.

Entities:  

Mesh:

Year:  1998        PMID: 9548329     DOI: 10.1007/s005950050141

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  3 in total

1.  Common variations in renal anatomy, affecting blood supply, form, and topography.

Authors:  B J ANSON; E H DASELER
Journal:  Surg Gynecol Obstet       Date:  1961-04

2.  Leiomyosarcoma of the inferior vena cava. Diagnosis and surgical management.

Authors:  D C Brewster; C A Athanasoulis; R C Darling
Journal:  Arch Surg       Date:  1976-10

Review 3.  Leiomyosarcoma of the inferior vena cava: analysis and search of world literature on 141 patients and report of three new cases.

Authors:  A Mingoli; R J Feldhaus; A Cavallaro; S Stipa
Journal:  J Vasc Surg       Date:  1991-11       Impact factor: 4.268

  3 in total
  1 in total

1.  Leiomyosarcoma of the inferior vena cava: Survival rate following radical resection.

Authors:  Frederico José Ribeiro Teixeira; Sergio Dias do Couto Netto; André Luis de Freitas Perina; Fabio C M Torricelli; Luciana Ragazzo Teixeira; Antonio Eduardo Zerati; Fabio de Oliveira Ferreira; Eduardo Hiroshi Akaishi; William Carlos Nahas; Edivaldo Massazo Utiyama
Journal:  Oncol Lett       Date:  2017-08-02       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.